AIFF
Firefly Neuroscience, Inc.
2.00$
+68.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 234.8% | – | 10,571.2% | 64.1% | 4,460.6% | 111.3% | 0.0% | 8.4% | 62.4% | 55.8% | 54.4% | 50.8% | 55.4% | |
| 100.0% | 100.0% | 100.0% | 35.9% | -4,360.6% | 100.0% | 100.0% | 91.6% | 37.6% | 44.2% | 45.6% | 49.2% | 44.6% | |
| 1,704.3% | 152.6% | 2,408.3% | 18.4% | 2,660.6% | 824.5% | 725.6% | 112.4% | 97.4% | 110.7% | 87.4% | 102.1% | 99.1% | |
| 795.7% | 4,900.0% | 4,708.3% | 49.8% | 5,778.8% | 3,679.2% | 3,693.0% | 459.2% | 517.3% | 485.4% | 343.5% | 296.1% | 399.9% | |
| 2,913.0% | 8,347.4% | 9,191.7% | 55.9% | 8,572.7% | 6,583.0% | 4,902.3% | 638.1% | 722.2% | 590.3% | 460.0% | 433.3% | 538.7% | |
| -2,813.0% | -8,247.4% | -9,091.7% | -20.1% | -12,933.3% | -6,483.0% | -4,802.3% | -546.5% | -684.5% | -546.1% | -414.4% | -384.0% | -494.2% | |
| 13.0% | 26.3% | 16.7% | 0.5% | 72.7% | 62.3% | 297.7% | 5.0% | 2.6% | 1.5% | 1.4% | 1.2% | 1.6% | |
| -2,826.1% | -5,663.2% | -9,350.0% | -20.5% | -12,997.0% | -7,137.7% | -30,069.8% | -611.7% | -680.2% | -601.7% | -413.2% | -386.0% | -506.2% | |
| – | 5.3% | – | – | – | 3.8% | – | 1.3% | – | 0.2% | – | – | – | |
| -2,826.1% | -5,668.4% | -9,350.0% | -20.5% | -12,997.0% | -7,141.5% | -30,069.8% | -613.0% | -680.2% | -601.9% | -413.2% | -386.0% | -506.2% | |
| -2,797.8% | -5,636.8% | -9,333.3% | -17.7% | -12,912.1% | -4,826.4% | -29,727.9% | -592.3% | -619.3% | -628.4% | -402.5% | -374.9% | -493.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.